therapy were classified as receiving platinum-based therapy. Patients documented in the VACCR as having undergone resection, surgery not otherwise specified, or tumor destruction were considered to have undergone surgery. Use of PET and brain MRI for
Search Results
Julian C. Hong, Matthew J. Boyer, Daphna Y. Spiegel, Christina D. Williams, Betty C. Tong, Scott L. Shofer, Michael J. Moravan, Michael J. Kelley, and Joseph K. Salama
Kenneth Offit
, noting that, in the case of PALB2, he anticipated that future studies may strengthen the ovarian cancer association. “Currently the American Cancer Society has suggested that lifetime risks be used to determine whether a patient should undergo MRI
Waleed A. Hassen, Farrok A. Karsan, Farhat Abbas, Yasar Beduk, Ahmed El-Khodary, Marwan Ghosn, Jamal Khader, Raja Khauli, Danny M. Rabah, Ali Shamseddine, and Sandy Srinivas
are generally available, MRI has more limited availability. Treatment The definitive and palliative treatment of prostate cancer has multiple regional challenges. Definitive treatment typically involves either surgery or radiotherapy, and
NCCN Guidelines Insights: Multiple Myeloma, Version 1.2020
Featured Updates to the NCCN Guidelines
Shaji K. Kumar, Natalie S. Callander, Jens Hillengass, Michaela Liedtke, Muhamed Baljevic, Erica Campagnaro, Jorge J. Castillo, Jason C. Chandler, Robert F. Cornell, Caitlin Costello, Yvonne Efebera, Matthew Faiman, Alfred Garfall, Kelly Godby, Leona Holmberg, Myo Htut, Carol Ann Huff, Yubin Kang, Ola Landgren, Ehsan Malek, Thomas Martin, James Omel, Noopur Raje, Douglas Sborov, Seema Singhal, Keith Stockerl-Goldstein, Carlyn Tan, Donna Weber, Alyse Johnson-Chilla, Jennifer Keller, and Rashmi Kumar
myeloma bone disease and stability of the spine. MRI is useful for discerning smoldering myeloma from MM. Because the disease burden in patients with smoldering myeloma is lower than in those with MM, imaging techniques with high sensitivity must be used
Katherine Cotangco, Mary Meram, and M. Patrick Lowe
pathology results revealed leiomyosarcoma, negative for estrogen and progesterone receptors. Fine-needle aspiration of a single lung nodule confirmed metastatic disease. Bone biopsy of her vertebral lesion was deferred secondary to location. However, MRI of
Jonathan R. Strosberg, Gary D. Hammer, and Gerard M. Doherty
Edited by Kerrin G. Robinson
. 22 Yun M Kim W Alnafisi N . 18 F-FDG PET in characterizing adrenal lesions detected on CT or MRI . J Nucl Med 2001 ; 42 : 1795 – 1799 . 23 Caoili EM Korobkin M Brown RK . Differentiating adrenal adenomas from nonadenomas using (18
Presenter: Ronald S. Go
medical history and complete physical examination], we recommend a PET/CT scan because many of the lesions appear fibrotic and are infiltrative in nature,” Dr. Go commented. If PET/CT is unavailable, a whole-body CT scan, MRI of the brain, and bone scan
Wylie Burke and Nancy Press
screening with MRI—what are the data for patients at high risk? N Engl J Med 2004 ; 351 : 497 – 500 . 11. Nelson HD Huffman LH Fu R Harris EL . Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility
Courtney Lawhn Heath, Laura J. Esserman, Robert R. Flavell, and Michelle E. Melisko
: evidence-based recommendations in initial staging . Tumour Biol 2017 ; 39 :1010428317728285. 10.1177/1010428317728285 29025377 4. Han S , Choi JY. Impact of 18F-FDG PET, PET/CT, and PET/MRI on staging and management as an initial staging
Rebecca P. Petersen and David H. Harpole Jr.
. Henschke CI Yankelevitz DF Kostis WJ . CT screening for lung cancer . Semin Ultrasound CT MRI 2003 ; 24 : 23 – 32 . 9. Kaneko M Eguchi K Ohmatusu H . Peripheral lung cancer: screening and detection with low-dose spiral CT versus radiography
